Family member and service provider experiences and perspectives of a digital surveillance and service navigation approach in multicultural context: a qualitative study in identifying the barriers and enablers to Watch Me Grow-Electronic (WMG-E) program with a culturally diverse community.

Publication date: Aug 24, 2024

Children and families from priority populations experienced significant psychosocial and mental health issues to the COVID-19 pandemic. Yet they also faced significant barriers to service access, particularly families from culturally and linguistically diverse (CALD) backgrounds. With most child and family health nurse clinics ceasing in-person consultations due to the pandemic, many children missed out on health and developmental checks. The aim of this study was to investigate the perspectives and experiences of family members and service providers from an urban, CALD community regarding the implementation of a digital, developmental surveillance, Watch Me Grow-Electronic (WMG-E) program. Semi-structured interviews were conducted with 17 family members, service navigators, and service providers in a multicultural community in South Western Sydney, Australia. This qualitative study is an implementation evaluation which formed as part of a larger, two-site, randomised controlled trial of the WMG-E program. A reflexive thematic analysis approach, using inductive coding, was adopted to analyse the data. Participants highlighted the comprehensive and personalised support offered by existing child and family health services. The WMG-E was deemed beneficial because the weblink was easy and quick to use and it enabled access to a service navigator who support family access to relevant services. However, the WMG-E was problematic because of technology or language barriers, and it did not facilitate immediate clinician involvement when families completed the weblink. Families and service providers in this qualitative study found that using WMG-E empowered parents and caregivers to access developmental screening and learn more about their child’s development and engage with relevant services. This beds down a new and innovative solution to the current service delivery gap and create mechanisms that can engage families currently not accessing services, and increases knowledge around navigating the health and social care services. Notwithstanding the issues that were raised by families and service providers, which include accessibility challenges for CALD communities, absence of clinical oversight during screening, and narrow scope of engagement with available services being offered, it is worth noting that improvements regarding these implementation factors must be considered and addressed in order to have longevity and sustainability of the program. The study is part of a large randomised controlled trial (Protocol No. 1. 0, Version 3. 1) was registered with ANZCTR (registration number: ACTRN12621000766819) on July 21st, 2021 and reporting of the trial results will be according to recommendations in the CONSORT Statement.

Open Access PDF

Concepts Keywords
Actrn12621000766819 Adult
Australia Australia
July Child
Nurse Child development
Psychosocial Child Health Services
COVID-19
Cultural Diversity
Developmental checks
Digital developmental surveillance
Family
Female
Health Services Accessibility
Humans
Interviews as Topic
Male
Middle Aged
Multicultural families
Patient Navigation
Qualitative Research
SARS-CoV-2
Service navigator

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH family health
disease IDO site
disease VO Gap
disease VO protocol
drug DRUGBANK Ilex paraguariensis leaf
disease IDO intervention
disease VO population
drug DRUGBANK Trestolone
drug DRUGBANK Serine
disease MESH chronic conditions
disease IDO process
disease MESH Autism
drug DRUGBANK Pentaerythritol tetranitrate
disease VO organ
drug DRUGBANK Methylergometrine
disease VO time
drug DRUGBANK Coenzyme M
drug DRUGBANK Tropicamide
disease MESH domestic violence
disease VO device
disease VO effective
drug DRUGBANK Etoperidone
drug DRUGBANK Diethylstilbestrol
disease MESH postpartum depression
disease MESH developmental disabilities
disease MESH autism spectrum disorder
disease VO Equity
disease VO effectiveness
disease VO USA
disease VO report
drug DRUGBANK Huperzine B
disease IDO symptom
disease MESH Manias

Original Article

(Visited 3 times, 1 visits today)